Why Pharmaceutical Airfreight Has A Large Carbon Footprint

Pharmaceutical cold chains are designed to minimize risk, but this often creates significant infrastructure and energy requirements.

Traditional pharma airfreight may involve:

• Reefer trucks on multiple transport legs
• Temperature-controlled airport storage
• Refrigerated backup systems
• Energy-intensive cold rooms
• Emergency shipments and re-routing
• Redundant contingency infrastructure

This infrastructure exists because pharmaceutical companies cannot tolerate product loss.

However, the result is a supply chain that is:

• Carbon intensive
• Operationally complex
• Expensive to maintain

As biologics and specialty medicines grow, this model becomes increasingly difficult to scale sustainably.

Why Product Loss Is Also A Sustainability Problem

Temperature excursions are not only operational failures. They are also emissions events.

When pharmaceutical product is lost, companies waste:

• Manufacturing emissions
• Packaging materials
• Transport emissions
• Refrigeration energy
• Raw materials and biologic inputs

For high-value biologics, the environmental footprint of product loss can be substantial.

Reducing excursions therefore improves:

• Product integrity
• Operational efficiency
• Sustainability performance

How Different Container Systems Affect Sustainability

Different pharmaceutical container systems create different emissions profiles depending on how they manage runtime, infrastructure dependency, and operational resilience.

Container Approach	Example Providers	Sustainability Strength	Main Sustainability Tradeoff
Active Containers	Envirotainer RAP/e2, CSafe RKN	Reusable containers	High energy dependence
Passive Containers	va-Q-tec passive solutions, Sonoco ThermoSafe	No energy dependence	Increased risk of product loss and heavy carbon footprint through dry ice or single-use packaging
Cold Corridor Models	Traditional passive + reefer infrastructure combinations	Energy usage can be predicted	High dependency on refrigerated infrastructure throughout the journey
Hybrid Containers	SkyCell 1500X, SkyCell 6500X	Long autonomous runtime with reduced infrastructure dependency. 50% less emissions than other container solutions	Greatest sustainability value on complex global lanes

 

Note: The most sustainable systems are generally those that reduce the need for:

• Continuous refrigerated infrastructure
• Emergency intervention
• Re-shipment after excursions
• Excessive redundancy across the cold chain

Why Infrastructure Dependency Drives Emissions

Many pharmaceutical cold chains compensate for uncertainty with more infrastructure.

This includes:

• Additional reefer trucking
• Backup refrigeration systems
• More cold storage capacity
• Greater airport energy consumption
• Emergency expedited shipments

The less confidence companies have in operational resilience, the more infrastructure they deploy.

This creates a direct link between:

• Operational uncertainty
  and
• Carbon intensity

Reducing infrastructure dependency is therefore one of the most effective ways to lower emissions in pharmaceutical logistics.

Why Long Runtime Improves Sustainability

Long autonomous runtime improves sustainability because shipments can tolerate disruption without relying on energy-intensive backup systems.

This reduces:

• Plug dependency
• Cold room usage
• Reefer truck reliance
• Emergency intervention during delays

It also reduces the likelihood of product loss and replacement manufacturing.

For complex international routes, resilience and sustainability are increasingly connected.

How Hybrid Systems Reduce Cold Chain Infrastructure Requirements

Hybrid systems are designed to combine:

• Long autonomous protection
• Reduced infrastructure dependency
• Operational resilience during delays

This can reduce the need for:

• Continuous refrigerated support
• Multiple cold storage handovers
• Extensive contingency infrastructure

Hybrid systems are particularly effective on:

• Long-haul international airfreight lanes
• Congested airport hubs
• Emerging-market routes
• Operationally complex biologics shipments

where infrastructure variability and delays are common.

How SkyCell Improves Sustainability In Pharma Airfreight

SkyCell’s sustainability approach focuses on reducing operational inefficiency across the pharmaceutical cold chain.

Long Autonomous Runtime With Lower Infrastructure Dependency

SkyCell hybrid containers maintain validated temperature ranges without requiring external power during transit.

• SkyCell 1500X. 270+ hours runtime
• SkyCell 6500X. 300+ hours runtime

This reduces dependency on:

• Airport plug infrastructure
• Reefer trucks
• Backup cold storage systems

Longer runtime also reduces excursion risk during delays, helping avoid emissions associated with product loss and replacement manufacturing.

Reduced Emissions Compared With Traditional Approaches

SkyCell reports:

• Up to 50% lower emissions compared with traditional solutions

This is supported by:

• Lower infrastructure dependency
• Higher payload efficiency
• Fewer containers required
• Lower tare weight
• Reduced need for emergency intervention

The company’s reusable leasing model also supports circularity by keeping containers in long-term operational use.

Visibility And Operational Efficiency

SkyCell combines physical protection with:

• Real-time monitoring
• Visibility infrastructure
• Operational coordination

Its network spans:

• 250+ IoT-monitored airports
• 20+ airline partnerships
• 1,900+ connected logistics suppliers

This allows earlier intervention during disruption, helping reduce:

• Emergency shipments
• Excessive contingency handling
• Operational inefficiency

Sustainability Intelligence Through Validaide

Through Validaide, SkyCell provides:

• Lane risk intelligence
• Emissions analysis
• Packaging comparison data

The platform has analyzed the carbon footprint of:

• 1,000+ packaging solutions

This helps pharmaceutical companies evaluate:

• Transport configurations
• Infrastructure requirements
• Sustainability tradeoffs

before shipments begin.

Why Sustainability And Resilience Are Increasingly Linked

Historically, pharmaceutical cold chains prioritized redundancy to reduce risk.

But as:

• Biologics scale globally
• Sustainability pressure increases
• Supply chains become more fragmented

companies are shifting toward systems that reduce both:

• Operational risk
  and
• Infrastructure intensity

The most sustainable cold chains are increasingly the ones that:

• Tolerate disruption safely
• Reduce unnecessary infrastructure
• Prevent product loss
• Optimize operations across the full journey

rather than relying on maximum refrigeration everywhere.

What This Means For Pharmaceutical Companies

Sustainable pharmaceutical airfreight is no longer just about packaging materials or carbon offsets.

It increasingly depends on:

• Runtime resilience
• Infrastructure efficiency
• Reduced product loss
• Visibility and intervention capability
• Smarter operational planning

Container systems that reduce uncertainty across the full logistics network can improve both sustainability and operational performance simultaneously.

Summary

• Pharmaceutical airfreight is carbon intensive because of refrigerated infrastructure and contingency systems
• Product loss and temperature excursions also create significant emissions impact
• Long-runtime systems reduce dependency on cold chain infrastructure
• Reduced infrastructure dependency lowers operational emissions
• Hybrid systems are increasingly used on complex global lanes because they improve both resilience and sustainability
• SkyCell combines long-runtime hybrid containers, operational visibility, and sustainability intelligence through Validaide to reduce emissions across pharmaceutical airfreight operations